Articles written by: Vazquez Maureen

Blueprint Medicines Corporation (BPMC) and Syros Pharmaceuticals Inc. (NASDAQ:SYRS) Comparing side by side

Both Blueprint Medicines Corporation (NASDAQ:BPMC) and Syros Pharmaceuticals Inc. (NASDAQ:SYRS) are each other’s competitor in the Biotechnology industry. Thus the compare of their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Blueprint Medicines Corporation […]

Comparison of 22nd Century Group Inc. (XXII) and Proteostasis Therapeutics Inc. (NASDAQ:PTI)

Both 22nd Century Group Inc. (NYSEAMERICAN:XXII) and Proteostasis Therapeutics Inc. (NASDAQ:PTI) are Biotechnology companies, competing one another. We will contrast their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 22nd Century Group Inc. 2 […]

Comparing of Cytosorbents Corporation (CTSO) and Invitae Corporation (NYSE:NVTA)

As Medical Laboratories & Research businesses, Cytosorbents Corporation (NASDAQ:CTSO) and Invitae Corporation (NYSE:NVTA), are affected by contrast. This especially applies to their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cytosorbents Corporation 7 10.18 […]

Reviewing Tiberius Acquisition Corporation (TIBRU)’s and Landcadia Holdings Inc. (NASDAQ:LCAHU)’s results

We will be comparing the differences between Tiberius Acquisition Corporation (NASDAQ:TIBRU) and Landcadia Holdings Inc. (NASDAQ:LCAHU) as far as risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership are concerned. The two businesses are rivals in the Conglomerates industry. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings […]

Reviewing Arvinas Inc. (ARVN)’s and Scholar Rock Holding Corporation (NASDAQ:SRRK)’s results

Arvinas Inc. (NASDAQ:ARVN) and Scholar Rock Holding Corporation (NASDAQ:SRRK) are two firms in the Biotechnology that compete against each other. Below is a comparison of their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Contrasting of Athersys Inc. (ATHX) and Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)

Athersys Inc. (NASDAQ:ATHX) and Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) compete against each other in the Biotechnology sector. We will compare them and contrast their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Athersys Inc. 2 […]

BioTime Inc. (BTX)’s Financial Results Comparing With Concert Pharmaceuticals Inc. (NASDAQ:CNCE)

Both BioTime Inc. (NYSEAMERICAN:BTX) and Concert Pharmaceuticals Inc. (NASDAQ:CNCE) are each other’s competitor in the Biotechnology industry. Thus the contrast of their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioTime Inc. 1 33.86 […]

Twin River Worldwide Holdings Inc. (TRWH) and Playa Hotels & Resorts N.V. (NASDAQ:PLYA) Contrasting side by side

Both Twin River Worldwide Holdings Inc. (NYSE:TRWH) and Playa Hotels & Resorts N.V. (NASDAQ:PLYA) are each other’s competitor in the Resorts & Casinos industry. Thus the compare of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per […]